1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,545 | 0,605 | 11:06 | |
| 0,555 | 0,590 | 11:08 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.08. | GRAND PHARMA (00512): DATE OF BOARD MEETING | 6 | HKEx | ||
| 24.07. | GRAND PHARMA Chinese Medicine Innovative Drug GPN01360 Completes First Patient Dosing in Phase III Clinical Trial in China | 2 | AASTOCKS | ||
| 23.07. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE FIRST PATIENT IS ENROLLED AND DOSED IN THE PHASE III CLINICAL TRIAL OF THE GROUP'S CLASS 1.1 INNOVATIVE ... | - | HKEx | ||
| 12.06. | Dividendenbekanntmachungen (12.06.2026) | 14.229 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIAN ASSET MANAGEMENT INC US10948W1036 0,1 USD 0,0863 EUR AEGON LTD BMG0112X1056 - 0,21 EUR ALBEMARLE CORPORATION US0126531013 0... ► Artikel lesen | |
| GRAND PHARMACEUTICAL GROUP Aktie jetzt für 0€ handeln | |||||
| 08.06. | GRAND PHARMA (00512): CONTINUING CONNECTED TRANSACTION | 2 | HKEx | ||
| 05.06. | GRAND PHARMA (00512): BYE-LAWS | 2 | HKEx | ||
| 05.06. | GRAND PHARMA (00512): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 5 JUNE 2026 | 1 | HKEx | ||
| 29.04. | GRAND PHARMA (00512): PROXY FORM FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 5 JUNE 2026 OR ANY ADJOURNMENT THEREOF | - | HKEx | ||
| 29.04. | GRAND PHARMA (00512): PROPOSED ADOPTION OF NEW BYE-LAWS | - | HKEx | ||
| 29.04. | GRAND PHARMA (00512): (1) GENERAL MANDATE TO REPURCHASE SHARES AND ISSUE NEW SHARES; (2) RE-ELECTION OF RETIRING DIRECTORS AND CONTINUOUS APPOINTMENT ... | - | HKEx | ||
| 29.04. | GRAND PHARMA (00512): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 29.04. | GRAND PHARMA (00512): 2025 ESG REPORT | - | HKEx | ||
| 29.04. | GRAND PHARMA (00512): NOTICE OF AVAILABILITY TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 29.04. | GRAND PHARMA (00512): 2025 ANNUAL REPORT | - | HKEx | ||
| 29.04. | GRAND PHARMA (00512): NOTICE OF AVAILABILITY TO REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 13.04. | EQS-News: Sirtex Medical Inc.: Die DOORwaY90-Studie von Sirtex Medical belegt eine 100-prozentige lokale Tumorkontrolle mit SIR-Spheres und setzt damit neue Maßstäbe bei der Y-90-Therapie für HCC | 408 | EQS Group (DE) | EQS-News: Sirtex Medical Inc.
/ Schlagwort(e): Sonstiges
Die DOORwaY90-Studie von Sirtex Medical belegt eine 100-prozentige lokale Tumorkontrolle mit SIR-Spheres und setzt damit... ► Artikel lesen | |
| 13.04. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE CLINICAL STUDY FOR THE TREATMENT OF HCC CONDUCTED IN THE UNITED STATES OF THE GROUP'S GLOBALLY INNOVATIVE ... | 3 | HKEx | ||
| 13.04. | Sirtex Medical Inc.: Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres, Setting a New Benchmark in Y-90 for HCC | 371 | PR Newswire | The DOORwaY90 study met its prespecified co-primary endpoints, achieving a best overall response rate (ORR) of 99%WOBURN, Mass., April 13, 2026 /PRNewswire/ -- Sirtex Medical ("Sirtex"),... ► Artikel lesen | |
| 08.04. | GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE GROUP ESTABLISHES A STRATEGIC PARTNERSHIP WITH THE UNIVERSITY OF HONG KONG | 1 | HKEx | ||
| 26.03. | GRAND PHARMA (00512): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 | 16 | HKEx |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,560 | -0,81 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,180 | +0,12 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| ECKERT & ZIEGLER | 13,590 | +0,82 % | Eckert & Ziegler: Q2 review: underlying business solid, valuation attractive: Despite a slight consensus miss with Q2, ... | Eckert & Ziegler reported H1 results: adj. EBIT grew 10% yoy ex license, with the margin up 1.2pp to 22.3%, while reported adj. EBIT fell 6% yoy to € 33.3m against a base carrying € 5m of license income... ► Artikel lesen | |
| MEDTRONIC | 79,24 | +0,20 % | Medtronic: What Experts Really Say About Overactive Bladder | Breaking down the myths, realities, and innovations shaping pelvic healthcare today. NORTHAMPTON, MA / ACCESS Newswire / August 18, 2026 / Bladder leaks, frequent trips to the bathroom, and pelvic discomfort... ► Artikel lesen | |
| M1 AESTHETICS | 12,700 | 0,00 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,065 | -2,69 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| FAMICORD | 2,850 | 0,00 % | FamiCord AG: Segmentwechsel | FamiCord AG,
Leipzig
ISIN: DE000A0BL849
bisheriges Segment: Regulierter Markt - Prime Standard
künftiges Segment: Freiverkehr - Scale
Änderung ab 19. August 2026
Frankfurt am Main, den 14.... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,520 | -1,56 % | Dividendenbekanntmachungen (27.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ATHOS IMMOBILIEN AG AT0000616701 - 0,8 EUR FVCBANKCORP INC US36120Q1013 0,07 USD 0,0615 EUR GAS PLUS SPA IT0004098510 - 0,25 EUR GERATHERM... ► Artikel lesen | |
| CERENOME | 2,465 | -3,52 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,53 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 95,27 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,970 | 0,00 % | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| HEARTFLOW | 46,760 | -0,09 % | Heartflow (HTFL) Rockets 46%: What Analysts Say and Where Hedge Funds Stand | ||
| ALIGNMENT HEALTHCARE | 12,930 | 0,00 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| BETA BIONICS | 19,490 | +0,05 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen |
Das Unternehmen GRAND PHARMACEUTICAL GROUP LTD kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,550 Euro und damit -1,79 % im Minus. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GRAND PHARMACEUTICAL GROUP LTD finden Sie auf Wallstreet Online.